AUTOANTIBODY REACTIVE WITH RNA POLYMERASE-III IN SYSTEMIC-SCLEROSIS

被引:186
作者
OKANO, Y [1 ]
STEEN, VD [1 ]
MEDSGER, TA [1 ]
机构
[1] UNIV PITTSBURGH, SCH MED,DEPT MED,DIV RHEUMATOL & CLIN IMMUNOL, 985 SCAIFE HALL, PITTSBURGH, PA 15261 USA
关键词
RNA POLYMERASE-III; SCLERODERMA; SYSTEMIC; AUTOANTIBODIES; SKIN DISEASE; BIOLOGICAL MARKERS;
D O I
10.7326/0003-4819-119-10-199311150-00007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the clinical significance of anti-RNA polymerase III antibody in systemic sclerosis (SSc). Design: A point prevalence study of autoantibody to RNA polymerase III and longitudinal examination of its clinical significance in patients with SSc and in controls. Setting: University medical center rheumatology practice. Patients: Two hundred fifty-two consecutive new patients with SSc and 170 controls (150 patients with other connective tissue diseases and 20 normal volunteers). Measurements: The presence of anti-RNA polymerase III antibody was determined by immunoprecipitation, immunoblotting, and immunodepletion studies. Main Results: Serum specimens from 57 of the 252 patients with SSc (23%; 95% CI, 18% to 28%) reacted with RNA polymerase III, compared with none of the specimens from 170 controls (0%; 95% CI, 0% to 2%). In 40 of these 57 specimens, immunoprecipitation studies also showed the presence of RNA polymerase I or II, or both. Anti-RNA polymerase III antibody was detected in sera from 50 of the 111 patients (45%) who had SSc with diffuse cutaneous involvement (dcSSc), 7 of 114 patients (6%) who had SSc with limited cutaneous involvement, and none of 27 patients with an SSc overlap syndrome (P < 0.001). Among patients with dcSSc, anti-RNA polymerase III antibody was more common than antitopoisomerase I antibody (45% compared with 27%; P = 0.008). Patients with anti-RNA polymerase III antibody had a statistically significant higher mean maximum skin thickness score but statistically significant lower frequencies of telangiectasias, inflammatory myopathy, restrictive lung disease, and serious cardiac abnormalities than did patients with antitopoisomerase I antibody. Conclusion: Anti-RNA polymerase III antibody is a new marker autoantibody for many patients who have SSc with diffuse or extensive cutaneous involvement.
引用
收藏
页码:1005 / 1013
页数:9
相关论文
共 27 条
[1]   PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[2]   SEROLOGICAL MARKERS IN PROGRESSIVE SYSTEMIC-SCLEROSIS - CLINICAL CORRELATIONS [J].
CATOGGIO, LJ ;
BERNSTEIN, RM ;
BLACK, CM ;
HUGHES, GRV ;
MADDISON, PJ .
ANNALS OF THE RHEUMATIC DISEASES, 1983, 42 (01) :23-27
[3]   THE CREST SYNDROME - A DISTINCT SEROLOGIC ENTITY WITH ANTICENTROMERE ANTIBODIES [J].
FRITZLER, MJ ;
KINSELLA, TD .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :520-526
[4]   TRANSCRIPTION BY RNA POLYMERASE-III [J].
GEIDUSCHEK, EP ;
TOCCHINIVALENTINI, GP .
ANNUAL REVIEW OF BIOCHEMISTRY, 1988, 57 :873-914
[5]   IDENTIFICATION OF AUTOANTIBODIES TO RNA POLYMERASE-II - OCCURRENCE IN SYSTEMIC-SCLEROSIS AND ASSOCIATION WITH AUTOANTIBODIES TO RNA POLYMERASE-I AND POLYMERASE-III [J].
HIRAKATA, M ;
OKANO, Y ;
PATI, U ;
SUWA, A ;
MEDSGER, TA ;
HARDIN, JA ;
CRAFT, J .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2665-2672
[6]   SARKOSYL DEFINES 3 INTERMEDIATE STEPS IN TRANSCRIPTION INITIATION BY RNA POLYMERASE-III - APPLICATION TO STIMULATION OF TRANSCRIPTION BY E1A [J].
KOVELMAN, R ;
ROEDER, RG .
GENES & DEVELOPMENT, 1990, 4 (04) :646-658
[7]   AUTOANTIBODY REACTIVE WITH 3 CLASSES OF RNA-POLYMERASES IN SERA FROM PATIENTS WITH SYSTEMIC-SCLEROSIS [J].
KUWANA, M ;
KABURAKI, J ;
MIMORI, T ;
TOJO, T ;
HOMMA, M .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1399-1404
[8]   ANTICENTROMERE ANTIBODY - CLINICAL CORRELATIONS AND ASSOCIATION WITH FAVORABLE PROGNOSIS IN PATIENTS WITH SCLERODERMA VARIANTS [J].
MCCARTY, GA ;
RICE, JR ;
BEMBE, ML ;
BARADA, FA .
ARTHRITIS AND RHEUMATISM, 1983, 26 (01) :1-7
[9]  
Medsger Jr TA, 1989, ARTHRITIS ALLIED CON, V11th, P1118
[10]   EPIDEMIOLOGY OF SYSTEMIC SCLEROSIS (SCLERODERMA) [J].
MEDSGER, TA ;
MASI, AT .
ANNALS OF INTERNAL MEDICINE, 1971, 74 (05) :714-+